RespireRx Pharmaceuticals Inc.
RSPI
$0.0021
$0.0011110.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -1.80M | -1.87M | -1.67M | -2.10M | -2.59M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 144.50K | 65.10K | 187.60K | 390.90K | 593.90K |
| Total Other Non-Cash Items | 130.50K | 129.90K | 88.30K | 99.50K | -83.90K |
| Change in Net Operating Assets | 1.27M | 1.46M | 1.25M | 1.47M | 1.77M |
| Cash from Operations | -247.60K | -216.50K | -149.90K | -143.80K | -310.60K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 103.40K | 212.80K | 245.00K | 237.80K | 275.80K |
| Total Debt Repaid | -19.50K | -57.40K | -95.20K | -95.20K | -75.70K |
| Issuance of Common Stock | -- | -- | -- | -- | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 170.00K | 70.00K | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -1.50K | 0.00 | 0.00 | 110.00K |
| Cash from Financing | 253.90K | 223.90K | 149.90K | 142.70K | 310.20K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 6.30K | 7.30K | -100.00 | -1.30K | -500.00 |